LifeMD (NASDAQ:LFMD) vs. Concentra Group Holdings Parent (NYSE:CON) Financial Contrast

Concentra Group Holdings Parent (NYSE:CONGet Free Report) and LifeMD (NASDAQ:LFMDGet Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.

Analyst Ratings

This is a breakdown of current recommendations for Concentra Group Holdings Parent and LifeMD, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concentra Group Holdings Parent 0 2 4 0 2.67
LifeMD 1 2 6 0 2.56

Concentra Group Holdings Parent presently has a consensus target price of $27.75, indicating a potential upside of 38.72%. LifeMD has a consensus target price of $9.25, indicating a potential upside of 119.19%. Given LifeMD’s higher probable upside, analysts clearly believe LifeMD is more favorable than Concentra Group Holdings Parent.

Insider & Institutional Ownership

35.5% of LifeMD shares are held by institutional investors. 6.6% of Concentra Group Holdings Parent shares are held by insiders. Comparatively, 18.4% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Concentra Group Holdings Parent and LifeMD”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Concentra Group Holdings Parent $1.90 billion 1.35 $166.54 million $1.20 16.67
LifeMD $212.45 million 0.96 -$18.88 million ($0.17) -24.82

Concentra Group Holdings Parent has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Concentra Group Holdings Parent has a beta of 0.72, suggesting that its stock price is 28% less volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500.

Profitability

This table compares Concentra Group Holdings Parent and LifeMD’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Concentra Group Holdings Parent 7.33% 48.42% 5.90%
LifeMD -1.82% N/A -6.44%

Summary

Concentra Group Holdings Parent beats LifeMD on 9 of the 14 factors compared between the two stocks.

About Concentra Group Holdings Parent

(Get Free Report)

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers’ compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.

About LifeMD

(Get Free Report)

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Receive News & Ratings for Concentra Group Holdings Parent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentra Group Holdings Parent and related companies with MarketBeat.com's FREE daily email newsletter.